Rfa-Dp-18-000

The funding opportunity RFA-DP-18-000 is issued by the Centers for Disease Control and Prevention (CDC) through its ERA division, part of the U.S. Department of Health and Human Services. The CDC is a leading federal public health agency focused on disease prevention, injury control, and health promotion. This funding opportunity is structured as a cooperative agreement, indicating that substantial involvement from CDC program staff will be expected throughout the lifecycle of funded projects. The purpose of this opportunity is to allow applicants to submit Type 6 applications, which are administrative supplements or competitive revisions to existing CDC awards. Though the specific project areas are not outlined in the synopsis, the opportunity falls under the broader category of "Health" and aligns with the Assistance Listing 93.136 — Injury Prevention and Control Research and State and Community-Based Programs. This suggests that projects may include expansion of existing injury prevention initiatives, enhancement of community-based public health programs, or continued support of epidemiological surveillance. The funding mechanism listed does not require cost sharing or matching, which simplifies participation for applicants. The expected number of awards is 100, though the total program funding, award floor, and award ceiling are not specified. This lack of financial data implies that budgets will vary depending on the scope and nature of proposed supplements. The CDC has not specified allowable or restricted spending in this notice, leaving those decisions likely to depend on the original scope of the parent grants to which these Type 6 applications will be tied. Eligible applicants include states, universities, counties, small businesses, and nonprofit organizations. The eligibility language is inclusive, permitting a broad array of entities to apply, provided they already hold an eligible CDC grant and seek additional support through this mechanism. The application process appears to require submission through Grants.gov, with no additional details provided on required forms, narrative components, or evaluation criteria. The application period is open from the date of posting through September 30, 2030. The original closing date was October 13, 2025, but this has since been extended. No pre-application steps such as letters of intent or concept papers are listed. Questions and concerns about the application process may be directed to Linton C Browning, a Grants Management Specialist at the CDC, reachable at 770-488-2756 or via email at lbrowning@cdc.gov. The long-term nature of the opportunity, combined with its categorization as a Type 6 administrative mechanism, suggests it is recurring and may follow a multi-year pattern. While no formal recurrence cadence is defined, the extended window and emphasis on continued support imply annual or as-needed submissions over the life of the parent award. Applicants should consult their program officers to determine if their project qualifies for supplementation under this notice.